Thane Wettig is the Chief Executive Officer of FibroGen, a biotechnology company focused on developing treatments for fibrotic diseases.
Thane Wettig is the Chief Executive Officer of FibroGen, a biotechnology company focused on developing treatments for fibrotic diseases. He is actively involved in insider trading for FibroGen stock, including purchasing 2,700 shares in November 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library